Basic info
Industry
pharmaceuticals
Sectors
Ygalo
melflufen
RRMM
Relapsed & Relapsed-Refractory Multiple Myeloma
Plasma Cell Myeloma
efficacy studies
oncology
PEnC
phase 3
phase 1
peptidase targeting
anti-angiogenic
peptide conjugated alkylator
alkylation
Peptidase Enhanced Cytotoxics
cytotoxicity
Orphan Drug
Multiple Myeloma
Date founded
2000